Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05473442 |
| Consolidated Lead Sponsor | Equilibre Biopharmaceuticals |
| Therapeutic Condition Cohort | Neurology, Psychiatry, and Pain |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 27 participants (ACTUAL) |
| Registered Start Date | 2022-12-27 |
| WhyStopped Classification | Funding / COVID / Operational |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| NYU Langone Health and Perlmutter Cancer Center | New York, NY | Open Hospital Dossier -> |
| University of Virginia | Charlottesville, VA | Open Hospital Dossier -> |
| Hadassah Medical Center | Jerusalem, Israel | Open Hospital Dossier -> |
| Rabin Medical Center | Petah Tikva, Israel | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.